On AD Scientific Index, you can explore the individual achievements of scientists in detail and evaluate their academic productivity based on total and recent H-index, i10 index, and citation counts. With Premium Membership, gain access to extended analyses and detailed data to assess and enhance your academic performance more effectively.
* Total H Index Rankings
Ranking Based
On Selection: 1
Breast cancer
angiogenesis
hypoxia
metabolism
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
210
80
0.381
* Total H Index Rankings
Ranking Based
On Selection: 2
Hemato-oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
134
68
0.507
* Total H Index Rankings
Ranking Based
On Selection: 3
Oncology
breast cancer
bone disease
trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
129
65
0.504
* Total H Index Rankings
Ranking Based
On Selection: 4
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
106
71
0.670
* Total H Index Rankings
Ranking Based
On Selection: 5
Prostate cancer
Voiding dissorder
imaging
trial design
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
98
64
0.653
* Total H Index Rankings
Ranking Based
On Selection: 6
oncology
radiation therapy
metastasis
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
97
46
0.474
* Total H Index Rankings
Ranking Based
On Selection: 7
Cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
95
69
0.726
* Total H Index Rankings
Ranking Based
On Selection: 8
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
95
54
0.568
* Total H Index Rankings
Ranking Based
On Selection: 9
Lymphoma. Late treatment toxicity
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
92
50
0.543
* Total H Index Rankings
Ranking Based
On Selection: 10
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
87
63
0.724
* Total H Index Rankings
Ranking Based
On Selection: 11
HIV assocaited malignancy
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
84
41
0.488
* Total H Index Rankings
Ranking Based
On Selection: 12
patient-reported outcomes
medical oncology
breast cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
54
0.684
* Total H Index Rankings
Ranking Based
On Selection: 13
Oncology
DNA damage response
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
40
0.506
* Total H Index Rankings
Ranking Based
On Selection: 14
Ovarian cancer
gene therapy
translational research
clinical trials
tumour microenvironment
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
54
0.730
* Total H Index Rankings
Ranking Based
On Selection: 15
Oncological Imaging
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
71
45
0.634
* Total H Index Rankings
Ranking Based
On Selection: 16
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
64
50
0.781
* Total H Index Rankings
Ranking Based
On Selection: 17
Medical Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
36
0.571
* Total H Index Rankings
Ranking Based
On Selection: 18
Clinical trials in breast cancer and gynaecological cancer
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
29
0.468
* Total H Index Rankings
Ranking Based
On Selection: 19
Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
59
55
0.932
* Total H Index Rankings
Ranking Based
On Selection: 20
oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
56
37
0.661
* Total H Index Rankings
Ranking Based
On Selection: 21
Rectal and anal cancer
clinical trials
radiotherapy research
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
39
0.709
* Total H Index Rankings
Ranking Based
On Selection: 22
Molecular pathology
Colorectal cancer
Biomarkers
Bioinformatics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
37
0.740
* Total H Index Rankings
Ranking Based
On Selection: 23
Medical oncology
GU oncology
Tumour biology
Clinical trials
Drug Development
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
38
0.776
* Total H Index Rankings
Ranking Based
On Selection: 24
Cancer Genetics and Genomics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
45
37
0.822
* Total H Index Rankings
Ranking Based
On Selection: 25
Oncology
Health Economics
Clinical Trials
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
37
0.841
Adrian L Harris
University of Oxford
Oxford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
210
80
0.381
Breast cancer
angiogenesis
hypoxia
metabolism
John Gribben
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
134
68
0.507
Robert Coleman
University of Sheffield
Sheffield, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
129
65
0.504
Oncology
breast cancer
bone disease
trials
dave cameron
University of Edinburgh
Edinburgh, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
106
71
0.670
Mark Emberton
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
98
64
0.653
Prostate cancer
Voiding dissorder
imaging
trial design
Ruth Muschel
University of Oxford
Oxford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
97
46
0.474
oncology
radiation therapy
metastasis
JA Ledermann
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
95
69
0.726
Robert Huddart
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
95
54
0.568
John Radford
University of Manchester
Manchester, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
92
50
0.543
Lymphoma. Late treatment toxicity
Nicholas James
University of Birmingham
Birmingham, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
87
63
0.724
Mark Bower
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
84
41
0.488
HIV assocaited malignancy
Galina Velikova
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
54
0.684
patient-reported outcomes
medical oncology
breast cancer
Nicola Curtin
Newcastle University
Newcastle upon Tyne, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
79
40
0.506
Oncology
DNA damage response
Iain Mcneish
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
74
54
0.730
Ovarian cancer
gene therapy
translational research
clinical trials
tumour microenvironment
Dow Mu Koh
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
71
45
0.634
Charlie Gourley
University of Edinburgh
Edinburgh, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
64
50
0.781
John Wagstaff
Swansea University
Swansea, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
63
36
0.571
Timothy Perren
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
62
29
0.468
Clinical trials in breast cancer and gynaecological cancer
David James Pinato
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
59
55
0.932
Hardev Pandha
University of Surrey
Guildford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
56
37
0.661
David Sebag Montefiore
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
55
39
0.709
Rectal and anal cancer
clinical trials
radiotherapy research
Enric Domingo
University of Oxford
Oxford, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
50
37
0.740
Molecular pathology
Colorectal cancer
Biomarkers
Bioinformatics
Syed A Hussain
University of Sheffield
Sheffield, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
49
38
0.776
Medical oncology
GU oncology
Tumour biology
Clinical trials
Drug Development
Maya Ghoussaini
University of Cambridge
Cambridge, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
45
37
0.822
Cancer Genetics and Genomics
Peter S Hall
University of Edinburgh
Edinburgh, United Kingdom
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
44
37
0.841
Oncology
Health Economics
Clinical Trials